Statistics

Data are presented as mean ± standard error of the mean, and p-values are

from paired Student t-test performed in Microsoft Excel. Additional statistics

including Chi Squares were performed by hand. Any p-value less than 0.05 was

considered statistically significant.

Acknowledgements

We wish to thank Leighton James, David Detwiler, Lance Johnson, and Kumar

Pandya for critical review and discussion of the manuscript. We would also like to

thank Deborah B. Dehart for help in sample preparation and Dr. C. Robert Bagnell

References

1. Thom, T., et al., Heart disease and stroke statistics--2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation, 2006. 113(6): p. e85-151.

2. González, A., B. López, and J. Díez, Myocardial fibrosis in arterial

hypertension. European Heart Journal Supplements, 2002. 4(Supplement D):

p. D18-D22.

3. Sun, Y. and K.T. Weber, Infarct scar: a dynamic tissue. Cardiovasc Res, 2000. 46(2): p. 250-6.

4. Sun, Y., et al., Cardiac remodeling by fibrous tissue after infarction in rats. J Lab Clin Med, 2000. 135(4): p. 316-23.

5. Sun, Y., et al., Angiotensin II, transforming growth factor-beta1 and repair in the infarcted heart. J Mol Cell Cardiol, 1998. 30(8): p. 1559-69.

6. Gordois, A., et al., The health care costs of diabetic nephropathy in the United States and the United Kingdom. J Diabetes Complications, 2004. 18(1): p. 18-

26.

7. Williams, E.J. and J.P. Iredale, Liver cirrhosis. Postgrad Med J, 1998.

74(870): p. 193-202.

8. Leask, A. and D.J. Abraham, The role of connective tissue growth factor, a multifunctional matricellular protein, in fibroblast biology. Biochem Cell Biol, 2003. 81(6): p. 355-63.

9. Ryseck, R.P., et al., Structure, mapping, and expression of fisp-12, a growth factor-inducible gene encoding a secreted cysteine-rich protein. Cell Growth Differ, 1991. 2(5): p. 225-33.

10. Surveyor, G.A. and D.R. Brigstock, Immunohistochemical localization of connective tissue growth factor (CTGF) in the mouse embryo between days 7.5 and 14.5 of gestation. Growth Factors, 1999. 17(2): p. 115-24.

11. Leask, A. and D.J. Abraham, All in the CCN family: essential matricellular signaling modulators emerge from the bunker. J Cell Sci, 2006. 119(Pt 23): p.

4803-10.

12. Shi-Wen, X., A. Leask, and D. Abraham, Regulation and function of

connective tissue growth factor/CCN2 in tissue repair, scarring and fibrosis.

Cytokine Growth Factor Rev, 2008. 19(2): p. 133-44.

13. Riser, B.L., et al., Urinary CCN2 (CTGF) as a possible predictor of diabetic nephropathy: preliminary report. Kidney Int, 2003. 64(2): p. 451-8.

14. Yang, D.H., et al., Identification of glycosylated 38-kDa connective tissue growth factor (IGFBP-related protein 2) and proteolytic fragments in human biological fluids, and up-regulation of IGFBP-rP2 expression by TGF-beta in Hs578T human breast cancer cells. J Clin Endocrinol Metab, 1998. 83(7): p.

2593-6.

15. Blom, I.E., R. Goldschmeding, and A. Leask, Gene regulation of connective tissue growth factor: new targets for antifibrotic therapy? Matrix Biol, 2002.

21(6): p. 473-82.

16. Ivkovic, S., et al., Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development.

Development, 2003. 130(12): p. 2779-91.

17. Nakanishi, T., et al., Overexpression of connective tissue growth

factor/hypertrophic chondrocyte-specific gene product 24 decreases bone density in adult mice and induces dwarfism. Biochem Biophys Res Commun, 2001. 281(3): p. 678-81.

18. Smerdel-Ramoya, A., et al., Skeletal overexpression of connective tissue growth factor impairs bone formation and causes osteopenia. Endocrinology, 2008. 149(9): p. 4374-81.

19. Panek, A.N., et al., Connective tissue growth factor overexpression in cardiomyocytes promotes cardiac hypertrophy and protection against pressure overload. PLoS One, 2009. 4(8): p. e6743.

20. Yokoi, H., et al., Overexpression of connective tissue growth factor in

podocytes worsens diabetic nephropathy in mice. Kidney Int, 2008. 73(4): p.

446-55.

21. Tong, Z., et al., Susceptibility to liver fibrosis in mice expressing a connective tissue growth factor transgene in hepatocytes. Hepatology, 2009. 50(3): p.

939-47.

22. Wu, S., et al., Conditional overexpression of connective tissue growth factor disrupts postnatal lung development. Am J Respir Cell Mol Biol. 42(5): p. 552-

63.

23. Sonnylal, S., et al., Selective expression of connective tissue growth factor in fibroblasts in vivo promotes systemic tissue fibrosis. Arthritis Rheum. 62(5): p.

1523-32.

25. Makhanova, N., et al., Salt-sensitive blood pressure in mice with increased expression of aldosterone synthase. Hypertension, 2008. 51(1): p. 134-40.

26. Tsai, Y.S., et al., Decreased PPAR gamma expression compromises perigonadal-specific fat deposition and insulin sensitivity. Mol Endocrinol, 2009. 23(11): p. 1787-98.

27. Tsai, Y.S., et al., Genetic variations in peroxisome proliferator-activated receptor gamma expression affect blood pressure. Proc Natl Acad Sci U S A, 2009. 106(45): p. 19084-9.

28. Hayashi, S. and A.P. McMahon, Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: a tool for temporally regulated gene

activation/inactivation in the mouse. Dev Biol, 2002. 244(2): p. 305-18.

29. Cheng, O., et al., Connective tissue growth factor is a biomarker and mediator of kidney allograft fibrosis. Am J Transplant, 2006. 6(10): p. 2292-306.

30. Kovalenko, E., et al., Validation of connective tissue growth factor

(CTGF/CCN2) and its gene polymorphisms as noninvasive biomarkers for the assessment of liver fibrosis. J Viral Hepat, 2009. 16(9): p. 612-20.

31. Kwon, S., et al., Expression of connective tissue growth factor in pancreatic cancer cell lines. Int J Oncol, 2007. 31(4): p. 693-703.

32. Tikellis, C., et al., Connective tissue growth factor is up-regulated in the diabetic retina: amelioration by angiotensin-converting enzyme inhibition.

Endocrinology, 2004. 145(2): p. 860-6.

33. Jacobsson, C. and G. Granstrom, Clinical appearance of spontaneous and induced first and second branchial arch syndromes. Scand J Plast Reconstr Surg Hand Surg, 1997. 31(2): p. 125-36.

34. Gupta, A.K., S. Kumar, and A. Jain, Bilateral first and second branchial cleft fistulas: a case report. Ear Nose Throat J, 2008. 87(5): p. 291-3.

35. Chai, Y. and R.E. Maxson, Jr., Recent advances in craniofacial morphogenesis. Dev Dyn, 2006. 235(9): p. 2353-75.

36. Sanford, L.P., et al., TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes.

Development, 1997. 124(13): p. 2659-70.

37. Tucker, R.P., Neural crest cells: a model for invasive behavior. Int J Biochem Cell Biol, 2004. 36(2): p. 173-7.

38. Igarashi, A., et al., Regulation of connective tissue growth factor gene

expression in human skin fibroblasts and during wound repair. Mol Biol Cell, 1993. 4(6): p. 637-45.

39. Ren, S., et al., Transforming growth factor-beta2 upregulates sphingosine kinase-1 activity, which in turn attenuates the fibrotic response to TGF-beta2 by impeding CTGF expression. Kidney Int, 2009. 76(8): p. 857-67.

40. Walls, J.R., et al., Three-dimensional analysis of vascular development in the mouse embryo. PLoS One, 2008. 3(8): p. e2853.

41. Carmeliet, P., et al., Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature, 1996. 380(6573): p. 435-9.

42. Suzuma, K., et al., Vascular endothelial growth factor induces expression of connective tissue growth factor via KDR, Flt1, and phosphatidylinositol 3- kinase-akt-dependent pathways in retinal vascular cells. J Biol Chem, 2000.

275(52): p. 40725-31.

43. Inoki, I., et al., Connective tissue growth factor binds vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis. FASEB J, 2002. 16(2): p. 219-21.

44. Fujiwara, Y., et al., Arrested development of embryonic red cell precursors in mouse embryos lacking transcription factor GATA-1. Proc Natl Acad Sci U S A, 1996. 93(22): p. 12355-8.

45. Graef, I.A., et al., Signals transduced by Ca(2+)/calcineurin and NFATc3/c4 pattern the developing vasculature. Cell, 2001. 105(7): p. 863-75.

46. Wakimoto, K., et al., Targeted disruption of Na+/Ca2+ exchanger gene leads to cardiomyocyte apoptosis and defects in heartbeat. J Biol Chem, 2000.

275(47): p. 36991-8.

47. Holzenberger, M., et al., Cre-mediated germline mosaicism: a method allowing rapid generation of several alleles of a target gene. Nucleic Acids Res, 2000. 28(21): p. E92.

48. Lakso, M., et al., Efficient in vivo manipulation of mouse genomic sequences at the zygote stage. Proc Natl Acad Sci U S A, 1996. 93(12): p. 5860-5.

49. Heffner, C. Strain Name: FVB/N-Tg(EIIa-cre)C5379Lmgd/J. 2010 [cited Jan. 29 2010]; Available from:

http://jaxmice.jax.org/research/cre/FVB_EIIA/FVB_EIIA_Main.html.

50. Mori, T., et al., Role and interaction of connective tissue growth factor with transforming growth factor-beta in persistent fibrosis: A mouse fibrosis model.

167

51. Piedrahita, J.A., et al., Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Proc Natl Acad Sci U S A, 1992. 89(10): p. 4471-5.

52. Leamy, L.J., et al., Genetic variance and covariance patterns for body weight and energy balance characters in an advanced intercross population of mice.

Genet Sel Evol, 2005. 37(2): p. 151-73.

53. Brocard, J., et al., Spatio-temporally controlled site-specific somatic

mutagenesis in the mouse. Proc Natl Acad Sci U S A, 1997. 94(26): p. 14559-

63.

54. Metzger, D., et al., Conditional site-specific recombination in mammalian cells using a ligand-dependent chimeric Cre recombinase. Proc Natl Acad Sci U S A, 1995. 92(15): p. 6991-5.

55. Sulik, K.K. and M.C. Johnston, Embryonic origin of holoprosencephaly: interrelationship of the developing brain and face. Scan Electron Microsc, 1982(Pt 1): p. 309-22.

CHAPTER 6